Completed PHASE2/PHASE3 INTERVENTIONAL 2-arm NCT02712125

Nitric Oxide Donors for Treatment of Isolated Oligohydramnios

Nitric Oxide Donors for Treatment of Isolated Oligohydramnios: A Pilot Study

Sponsor: Benha University

Conditions Isolated (Idiopathic) Oligohydramnios

Interventions Placebo isosorbide mononitrate

Updated 6 times since 2017 Last updated: Mar 14, 2016 Started: Aug 31, 2013 Primary completion: Jun 30, 2015 Completion: Aug 31, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02712125, this PHASE2/PHASE3 trial focuses on Isolated (Idiopathic) Oligohydramnios and remains completed. Sponsored by Benha University, it has been updated 6 times since 2013, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2/PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2/PHASE3

Phase: PHASE2_PHASE3 → PHASE2/PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2_PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2_PHASE3
Feb 2017 — Jun 2018 [monthly]

Completed PHASE2_PHASE3

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Completed PHASE2_PHASE3

First recorded

Aug 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Benha University

Data source: Benha University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.